Company intelligence / Profile preview

FHI 360

Durham, North Carolina, United Statesfhi360.org ↗

Ownership: Private
Employees: ~4000
Development stage: Other

Overview

FHI 360 has contributed to major global public health advances through research, program implementation, and capacity building. Notably participated in CAPRISA 004 trial showing efficacy of vaginal gel for HIV prevention[4]. Runs large-scale programs for infectious diseases, maternal/child/reproductive health globally.

Therapeutic areas: PsychiatryWomen's HealthInfectious Diseases
Modalities: Small moleculeBiologicDevice
Industry: Academic Hospital/University/Research

Partnerships

USAIDBill & Melinda Gates FoundationGlobal Fund to Fight AIDS/TB/MalariaUK Foreign Commonwealth & Development Officelocal governmentsNGOs globally

Beyond the preview

Go deeper on FHI 360.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FHI 360.

Explore the full profile